眼部不良事件与瓦雷尼克林溶液使用的关联:基于人口的研究
Moiz Lakhani1,2, Angela T H Kwan1,2, Anne Xuan-Lan Nguyen2,3
1Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Expert opinion on drug safety
|February 8, 2025
概括
瓦伦尼克林溶液是一种新的干眼治疗方法,与现实世界中使用的Systane相比,显示出水,视力障碍和光恐惧症的几率增加. 进一步的药物监测对于监测干眼病 (DED) 患者的安全性至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 瓦伦尼克林溶液是第一个FDA批准的鼻喷雾剂,用于增强干眼疾病 (DED) 的眼膜产量.
- 将瓦雷尼克林溶液与传统的DED疗法进行比较的全面安全数据有限.
- 这项研究调查了与真实世界瓦雷尼克林溶液使用相关的眼部不良事件 (AE).
研究的目的:
- 评估瓦雷尼克林溶液在治疗干眼疾病 (DED) 中的安全性.
- 为了确定与对照疗法相比,使用瓦雷尼克林溶液报告的眼部不良事件 (AE) 是否不成比例.
- 通过营销后药监测识别潜在的安全信号.
主要方法:
- 一个观察性,基于人群的药监测研究.
- 分析食品和药物管理局不良事件报告系统 (FAERS) 的数据,从最初到2024年4月.
- 使用报告几率比率 (ROR) 用鼻液和Systane作为对照.
主要成果:
- 总共有1,125个不良事件 (AE) 报告与瓦伦尼克林溶液有关.
- 与鼻腔盐水相比,没有发现眼部AE的不成比例报告.
- 与Systane相比,瓦伦尼克林溶液显示出流,视力障碍和光恐惧症的几率明显更高.
结论:
- 虽然无法最终确定因果关系,但研究结果表明,与Systane相比,瓦雷尼克林溶液具有潜在的风险信号.
- 强调营销后药监测对于监测新型DED治疗的长期安全的重要性.
- 需要进一步调查瓦雷尼克林溶液在干眼疾病中的安全性.
相关概念视频
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Direct-Acting Cholinergic Agonists: Therapeutic Uses
673
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
673
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Stimulants
157
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
157
Cholinergic Antagonists: Pharmacokinetics
401
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
401
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


